The comment I posted, which might or might not be published to the site (comments are moderated):
So many things wrong with this article.
1) William Campbell did not knock ivermectin. When asked about it’s efficacy with covid-19, he said he didn’t know — which is the answer any responsible researcher MUST say because the clinical trials are still underway.
2) Ivermectin isn’t just an antiparasitic. If you search PubMed for “ivermectin antiviral” you’ll get 54 hits. It’s been shown to clear the dengue fever virus.
3) There are 14 ivermectin vs covid-19 trials on ClinicalTrials, as you write — and 2 more on the EU equivalent, plus perhaps 6-8 unregistered trials.
4) Derek Lowe did very little research for his blog about ivermectin. He originally posted that there was only 1 clinical trial underway when there were 10; he updated later when I let him know there were 10. His argument that the concentration of ivermectin would be too high, based on the Monash result, is just an echo of the two letters that accompanied Monash on Lancet. It’s also just plain bad science, projecting from in vitro results, which Mr. Lowe should know. He may be brilliant on other topics but he’s very very far from an ivermectin expert.
5) You neglect to mention the amazing “Usefulness of Ivermectin…” study by a team out of UofUtah and Harvard that found that ivermectin lowered fatalities 83%.
6) You fail to mention the finding that ivermectin binds to the importin proteins that the coronavirus otherwise uses to enter to nucleus, where it replicates. Ivermectin stops that.
https://pubmed.ncbi.nlm.nih.gov/32135219/
If someone hired me to write a hit-piece about ivermectin it would read a lot like this. You insinuate negative opinions that aren’t there. You uncritically cite the comments of an ivermectin amateur. It is not impressive journalism, in my opinion.
Get in touch if you want me to write a positive article about ivermectin. There is a lot of good news.
I believe the first clinical trial is scheduled to complete on June 10.
[-] TrumpLyftAlles | 3 points | May 26 2020 03:40:38
The comment I posted, which might or might not be published to the site (comments are moderated):
So many things wrong with this article.
1) William Campbell did not knock ivermectin. When asked about it’s efficacy with covid-19, he said he didn’t know — which is the answer any responsible researcher MUST say because the clinical trials are still underway.
2) Ivermectin isn’t just an antiparasitic. If you search PubMed for “ivermectin antiviral” you’ll get 54 hits. It’s been shown to clear the dengue fever virus.
3) There are 14 ivermectin vs covid-19 trials on ClinicalTrials, as you write — and 2 more on the EU equivalent, plus perhaps 6-8 unregistered trials.
4) Derek Lowe did very little research for his blog about ivermectin. He originally posted that there was only 1 clinical trial underway when there were 10; he updated later when I let him know there were 10. His argument that the concentration of ivermectin would be too high, based on the Monash result, is just an echo of the two letters that accompanied Monash on Lancet. It’s also just plain bad science, projecting from in vitro results, which Mr. Lowe should know. He may be brilliant on other topics but he’s very very far from an ivermectin expert.
5) You neglect to mention the amazing “Usefulness of Ivermectin…” study by a team out of UofUtah and Harvard that found that ivermectin lowered fatalities 83%.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3580524
6) You fail to mention the finding that ivermectin binds to the importin proteins that the coronavirus otherwise uses to enter to nucleus, where it replicates. Ivermectin stops that.
https://pubmed.ncbi.nlm.nih.gov/32135219/
If someone hired me to write a hit-piece about ivermectin it would read a lot like this. You insinuate negative opinions that aren’t there. You uncritically cite the comments of an ivermectin amateur. It is not impressive journalism, in my opinion.
Get in touch if you want me to write a positive article about ivermectin. There is a lot of good news.
I believe the first clinical trial is scheduled to complete on June 10.
Thanks for posting this.
permalink